- Home
- CHCT vs LAB Comparison
CHCT vs LAB Comparison
Compare CHCT & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHCT | LAB |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 410.6M | 488.4M |
| IPO Year | 2015 | 2008 |
Fundamental Metrics
Financial Performance| Metric | CHCT | LAB |
|---|---|---|
| Price | $16.96 | $1.18 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $18.33 | $1.35 |
| AVG Volume (30 Days) | 295.5K | ★ 1.3M |
| Earning Date | 05-20-2026 | 05-18-2026 |
| Dividend Yield | ★ 11.36% | N/A |
| EPS Growth | ★ 134.78 | 44.68 |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $121,195,000.00 | $101,937,000.00 |
| Revenue This Year | $9.06 | N/A |
| Revenue Next Year | $8.61 | N/A |
| P/E Ratio | $210.25 | ★ N/A |
| Revenue Growth | ★ 4.67 | N/A |
| 52 Week Low | $13.23 | $0.92 |
| 52 Week High | $19.01 | $1.72 |
Technical Indicators
Market Signals| Indicator | CHCT | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 47.03 | 39.62 |
| Support Level | $16.46 | $1.09 |
| Resistance Level | $17.24 | $1.41 |
| Average True Range (ATR) | 0.50 | 0.06 |
| MACD | -0.16 | 0.00 |
| Stochastic Oscillator | 39.71 | 38.46 |
Price Performance
Historical ComparisonAbout CHCT Community Healthcare Trust Incorporated
Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. The company derives majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.